 |
| Add caption |
Patients with severe disease usually experience anxiety so as preparing dying. To overcome these fears. Scientists suggest that administration of psychotropic drugs and MDMA Psycolibin because it can make patients calmer and more optimistic.
A chronic colon tumor patients aged 55 years and named Pam Sakuda diagnosed only has the life span of 6-14 months. Sakuda determined to slow down the dangers of the disease to run several kilometers every day, even during the grueling treatment. With optimistic because eating Psycolibin, Sakuda finally able to survive for four years.
To overcome his fear, Sakuda follow research conducted by Charles Grob, a psychiatrist and researcher at Harbor-University of California Los Angeles Medical Center. Grob give psilocybin to patients with end-stage cancer to see its effect in reducing the fear of death. Psycolibin psychoactive substances, which are substances that can affect consciousness and cause people to hallucinate.
When the study was completed in 2008, the results showed that administration of psilocybin to chronically ill patients are incurable quite safe, and effective in reducing anxiety and depression in the face of death.
"I did not have a definite answer why these drugs can alleviate the fear of death. But we know that in ancient times, people who have a spiritual experience transformative had a very different view towards himself and the world so that they can face death calmly, "Grob said as reported by the New York Times.
Dr. John Halpern, head of Integrative Psychiatry Laboratory at McLean Hospital using MDMA to ease the anxiety facing death to end-stage cancer patients. Or MDMA (3,4-methylenedioxy-N-methylamphetamine) is one type of amphetamine known as ecstasy.
Previous research conducted showed that MDMA Michael Mithoefer effectively cope with PTSD (post-traumatic stress syndrome) severe. Dr. Halpern also examine case studies of headache sufferers who took LSD and admitted to symptoms of pain and then be greatly reduced.
The results showed that the patient's anxiety level is reduced drastically after 1-3 months of treatment, and decreased anxiety occurs in a sustainable manner. Although this research is promising, Grob and other researchers are still cautious to conclusions because of the use of these drugs may trigger controversy.
Over the years, Roland Griffiths of Johns Hopkins Bayview Medical Center have been studying the effects of psilocybin on healthy people. He wanted to see if in small doses, the drug can induce a trance or lose consciousness.
Griffiths and his colleagues found that psilocybin doses of 20-30 mg not only trigger a trance, but also cause a positive change in attitude, mood and behavior of research participants.
"After the experience of trance, a person's fear of death is often much reduced. 14 months after participating in the study, 94% of study participants said that the experience of his trance it is one of the most meaningful experiences in his life," said Griffiths.
As reported in the Journal of Psychopharmacology, Griffiths give psychological tests 1-14 months later.
As a result, more study participants agreed with statements such as 'death is not an end but part of a process' and 'I do not put an end to the death of my personal existence'.,
0 Response to "Severe Pain Patients who fear Dead Can Calm Because medicine is"
Posting Komentar